Hyderabad|India|March'2010: Incidence of cancer is fast approaching epidemic proportions. It is projected that 1 in every 8 to 10 individuals carry the risk of cancer. This can seriously threaten the socio-economic fabric in India and managing this disease burden is bound to challenge the nation in a big way. However the good news is that cancer is preventable and if it does occur, it is completely curable. Technological innovation, newer pharmaceutical agents and a greater understanding of the disease process have created multiple options to manage cancer. Apollo Hospitals has always strived to identify gaps in the Indian healthcare system and bridge them with appropriate solutions. Apollo Cancer Hospitals is a step in bridging the national 'cancer gap'.

The new Apollo Cancer Hospitals and the Novalis TX will be inaugurated by H.E. Sri. Narasimham, Governor of Andhra Pradesh on 20 March.

Apollo Cancer Hosptials Network
With hospitals in Chennai, Hyderabad, New Delhi, Kolkatta, Bengaluru, Madurai and Bilaspur, Apollo Hospitals offers state-of-the-art technology and world-class services across the country. Cyberknife, Novalis TX, Linear Accelerators, HDR Brachytherapy, Bone Marrow Transplant Units, Leukemia Units, Pediatric Oncology and a range of other facilities ensure delivery of the highest standards of care across the network with results that benchmark with the best in the world. Apollo Hospitals has been at the forefront of bringing new technology in to India. Cyberknife in Chennai and Novalis TX in Hyderabad and Kolkatta are two recent examples.

Apollo Cancer Hospitals, Hyderabad
Apollo Cancer Hospitals, Hyderabad offers a comprehensive range of services spanning across the entire spectrum of cancer care. It is the first cancer hospital offering super-specialty cancer care with a number of unique features :

Empowering the community : Knowledge is power and Apollo Cancer Hospitals offers an extensive bank of information in the unique Cancer Resource Centre.

Screening : Apollo Cancer Check is the most comprehensive screening check for identifying cancer at it's earliest stage. Cancer is curable when detected early and Apollo Cancer Hospitals will focus on screening large sections of our population for early detection of cancer.

Diagnosis : Apollo Cancer Hospitals has the best range of cancer diagnostics including a PET-CT Scan with onsite cyclotron.

Treatment : The latest options in radiotherapy, chemotherapy and onco-surgery are available under roof. Novalis TX the most versatile technology to treat cancer is an integral part of Apollo Cancer Hospitals

Tumor Board : To ensure optimal treatment protocols for every patient, a board consisting of radiation, medical and surgical oncologists supported by onco-radiologists and onco-pathologists analyzes the patients details before finalizing the treatment.

Rehab : Cancer rehab is a critical component of managing cancer as it helps in coping with the diseases and getting back to normal much earlier

Multi-specialty support : The support of over 50 specialties and super-specialties is of critical importance as cancer often demands multi-specialty care

Apollo Cancer Hospitals set up at a cost of Rs.100 crores offers the best environment for a cancer victim and their families to manage not just the disease but the psycho-social component of the disease also. Clinical protocols and pathways based on globally accepted evidence based principles will ensure higher cure rates and will facilitate the cancer victim to return to normal faster.

NOVALIS TX - Worlds most versatile technology to treat cancer
Novalis Tx™ is one of the most precise, non-invasive radiosurgery treatments available for cancerous and non-cancerous conditions of the entire body. Novalis Tx represents a new standard in radiosurgery treatment, featuring advanced technologies that deliver highly precise treatment while protecting surrounding healthy tissue. Novalis Tx offers one of the fastest treatment times available-minutes, not hours-giving new hope to patients with tumors once considered untreatable.

Reachout's News Bureau
March' 2010